C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling overall survival Prediction in Pancreatic Cancer Patients.

Schlick, K; Magnes, T; Huemer, F; Ratzinger, L; Weiss, L; Pichler, M; Melchardt, T; Greil, R; Egle, A. J Clin Med. 2019 Oct 25;8(11):1791. doi: 10.3390/jcm8111791.

Lignans and sesquiterpene lactones from Hypochaeris radicata subsp. neapoli-tana (Asteraceae, Cichorieae).

Shulha, O; Cicek, SS; Wangensteen, H; Kroes, J; Mader, M; Girreser, U; Sendker, J; Johrer, K; Greil, R; Schuhly, W; Mangoni, A; Grauso, L; van Thriel, C; Zidorn, C. Phytochemistry. 2019 Sep;165:112047. doi: 10.1016/j.phytochem.2019.05.020. Epub 2019 Jun 13.

Randomized phase III study (ADMYRE) of plitidepsin in combination with dexa-methasone vs. dexamethasone alone in patients with relapsed/refractory mul-tiple myeloma.

Spicka, I; Ocio, EM; Oakervee, HE; Greil, R; Banh, RH; Huang, SY; DxxxRozario, JM; Dimopoulos, MA; Martinez, S; Extremera, S; Kahatt, C; Alfaro, V; Carella, AM; Meuleman, N; Hajek, R; Symeonidis, A; Min, CK; Cannell, P; Ludwig, H; Sonneveld, P; Mateos, MV. Ann Hematol. 2019 Sep;98(9):2139-2150. doi: 10.1007/s00277-019-03739-2. Epub 2019 Jun 25.

Systemic treatment of metastatic breast cancer: SABCS 2018.

Westphal, T; Gampenrieder, SP; Greil, R. MEMO-MAG EUR MED ONC. 2019; 12(3): 253-256.

Pixantrone demonstrates significant in vitro activity against multiple myeloma and plasma cell leukemia.

Willenbacher, E; Johrer, K; Willenbacher, W; Flogel, B; Greil, R; Kircher, B. Ann Hematol. 2019 Nov;98(11):2569-2578. doi: 10.1007/s00277-019-03797-6. Epub 2019 Oct 18.

Cytotoxic Properties of Damiana ( Turnera diffusa) Extracts and Constituents and A Validated Quantitative UHPLC-DAD Assay.

Willer, J; Johrer, K; Greil, R; Zidorn, C; Cicek, SS. Molecules. 2019 Feb 28;24(5):855. doi: 10.3390/molecules24050855.

Exome sequencing of the TCL1 mouse model for CLL reveals genetic hetero-geneity and dynamics during disease development.

Zaborsky, N; Gassner, FJ; Höpner, JP; Schubert, M; Hebenstreit, D; Stark, R; Assla-ber, D; Steiner, M; Geisberger, R; Greil, R; Egle, A. Leukemia. 2019 Apr;33(4):957-968. doi: 10.1038/s41375-018-0260-4. Epub 2018 Sep 27.

The EndoPredict score predicts response to neoadjuvant chemotherapy and neoendocrine therapy in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients from the ABCSG-34 trial.

Dubsky, PC; Singer, CF; Egle, D; Wette, V; Petru, E; Balic, M; Pichler, A; Greil, R; Petzer, AL; Bago-Horvath, Z; Fesl, C; Meek, SM; Kronenwett, R; Rudas, M; Gnant, M; Filipits, M. Eur J Cancer . 2020 Jul;134:99-106. doi: 10.1016/j.ejca.2020.04.020. Epub 2020 Jun 2.

Endocrine therapy with or without whole breast irradiation in low-risk breast cancer patients after breast-conserving surgery: 10-year results of the Austrian Breast and Colorectal Cancer Study Group 8A trial.

Fastner, G; Sedlmayer, F; Widder, J; Metz, M; Geinitz, H; Kapp, K; Fesl, C; Sölkner, L; Greil, R; Jakesz, R; Kwasny, W; Heck, D; Bjelic-Radisic, V; Balic, M; Stöger, H; Wieder, U; Zwrtek, R; Semmler, D; Horvath, W; Melbinger-Zeinitzer, E; Wiesholzer, M; Wette, V; Gnant, M. Eur J Cancer. 2020 Mar;127:12-20. doi: 10.1016/j.ejca.2019.11.024. Epub 2020 Jan 18.

Dysphagia in the Context of a Serious Systemic Disease.

Ferstl, FS; Gampenrieder, SP; Renneberg, F; Roesch, S. Dysphagia. 2020 Jul 22. doi: 10.1007/s00455-020-10155-6. Online ahead of print.